1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. News
  7. Summary
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
Real-time Estimate Cboe BZX  -  01:17 2022-07-01 pm EDT
163.50 USD   +1.02%
06/30BEIGENE : Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma - Form 8-K
PU
06/30BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/30BeiGene Says Esophageal Cancer Combination Therapy Improved Overall Survival in Phase 3 Trial
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Asian ADRs Climb Higher in Tuesday Trading

05/10/2022 | 10:37am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
111, INC. 5.34% 2.17 Delayed Quote.-41.14%
ASLAN PHARMACEUTICALS LIMITED 1.23% 0.5011 Delayed Quote.-55.80%
BEIGENE, LTD. 0.47% 162.49 Delayed Quote.-40.26%
HDFC BANK LIMITED 0.43% 1353.75 Delayed Quote.-8.88%
JUPAI HOLDINGS LIMITED -71.36% 0.0401 Delayed Quote.-86.41%
LEJU HOLDINGS LIMITED -8.51% 2.15 Delayed Quote.-74.02%
PLDT INC. -0.60% 1670 End-of-day quote.-7.84%
SEA LIMITED -0.03% 66.9137 Delayed Quote.-70.11%
SECOO HOLDING ADR A -0.45% 0.223 Delayed Quote.-53.33%
SIFY TECHNOLOGIES LIMITED -1.54% 1.92 Delayed Quote.-39.01%
SO-YOUNG INTERNATIONAL INC. 4.03% 0.8912 Delayed Quote.-73.14%
SY HOLDINGS GROUP LIMITED -0.17% 5.89 Delayed Quote.-24.00%
UNITED MICROELECTRONICS CORPORATION -2.81% 38.05 End-of-day quote.-41.46%
UXIN LIMITED 7.95% 0.4541 Delayed Quote.-73.42%
All news about BEIGENE, LTD.
06/30BEIGENE : Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tis..
PU
06/30BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/30BeiGene Says Esophageal Cancer Combination Therapy Improved Overall Survival in Phase 3..
MT
06/30BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Ti..
BU
06/30BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Ti..
CI
06/27BeiGene Grants Share Options, Restricted Share Units
MT
06/26Antengene Corporation Limited Announces Clinical Trial Collaboration with BeiGene, Ltd...
CI
06/24Asian ADRs Climb Higher in Friday Trading
MT
06/22BEIGENE : Announces Acceptance of Supplemental Biologics License Application in China for ..
PU
06/22INSIDER SELL : Beigene
MT
More news
Analyst Recommendations on BEIGENE, LTD.
More recommendations
Financials (USD)
Sales 2022 1 434 M - -
Net income 2022 -1 399 M - -
Net cash 2022 3 045 M - -
P/E ratio 2022 -11,2x
Yield 2022 -
Capitalization 16 726 M 16 726 M -
EV / Sales 2022 9,54x
EV / Sales 2023 7,05x
Nbr of Employees 8 300
Free-Float 99,0%
Chart BEIGENE, LTD.
Duration : Period :
BeiGene, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIGENE, LTD.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 161,85 $
Average target price 303,74 $
Spread / Average Target 87,7%
EPS Revisions
Managers and Directors
John V. Oyler Director
Xiao Bin Wu President & Chief Operating Officer
Julia Wang Chief Financial & Accounting Officer
Lai Wang Global Head-Research & Development
Christiane Langer Senior Vice President-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
BEIGENE, LTD.-40.26%16 726
GILEAD SCIENCES, INC.-14.87%77 529
VERTEX PHARMACEUTICALS28.32%72 069
REGENERON PHARMACEUTICALS, INC.-6.40%63 692
WUXI APPTEC CO., LTD.-12.30%45 031
BIONTECH SE-42.16%36 234